CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience
Mijin Kim, Jee Hee Yoon, Jonghwa Ahn, Min Ji Jeon, Hee Kyung Kim, Dong Jun Lim, Ho-Cheol Kang, In Joo Kim, Young Kee Shong, Tae Yong Kim, Bo Hyun Kim
Endocrinol Metab. 2020;35(3):587-594.   Published online September 22, 2020
DOI: https://doi.org/10.3803/EnM.2020.687

Excel Download

Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience
Mijin Kim, Jee Hee Yoon, Jonghwa Ahn, Min Ji Jeon, Hee Kyung Kim, Dong Jun Lim, Ho-Cheol Kang, In Joo Kim, Young Kee Shong, Tae Yong Kim, Bo Hyun Kim
Endocrinology and Metabolism. 2020;35(3):587-594   Crossref logo
Link1 Link2 Link3
Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
Hari Deshpande, Julie Sosa, Marler
OncoTargets and Therapy. 2011;209   Crossref logo
Link1
Vandetanib in advanced hereditary medullary thyroid cancer
Jame Abraham
Community Oncology. 2011;8(8):353-354   Crossref logo
Link1 Link2
Role of vandetanib in the management of medullary thyroid cancer
Maryse Brassard, Rondeau
Biologics: Targets and Therapy. 2012;59   Crossref logo
Link1
Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer
Viktoria F. Koehler, Pia Adam, Karin Frank-Raue, Friedhelm Raue, Elke Berg, Eva Hoster, Stephanie Allelein, Matthias Schott, Matthias Kroiss, Christine Spitzweg,
Thyroid. 2021;31(3):459-469   Crossref logo
Link1 Link2
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
M. Schott
Yearbook of Endocrinology. 2012;2012:153-155   Crossref logo
Link1 Link2
Vandetanib: A Guide to Its Use in Advanced Medullary Thyroid Cancer
Gillian M. Keating, Katherine A. Lyseng-Williamson, James E. Frampton
BioDrugs. 2012;26(6):431-435   Crossref logo
Link1 Link2 Link3
Vandetanib—a new therapeutic option in advanced medullary thyroid cancer
Linda Koch
Nature Reviews Endocrinology. 2011;8(1):1-1   Crossref logo
Link1 Link2 Link3
Surgical Management of Invasive Medullary Thyroid Carcinoma
Scott Coman, Raefe Gundelach
Medullary Thyroid Cancer. 2016;127-136   Crossref logo
Link1
Advanced medullary thyroid cancer: pathophysiology and management
Ana Luiza Maia, Ferreira, Siqueira, Ceolin
Cancer Management and Research. 2013;57   Crossref logo
Link1